Anti-Smith (anti-Sm) antibody

Anti-Smith, or anti-Sm, is an autoantibody directed against a group of proteins bound to small nuclear RNA inside the cell. It is one of the antibodies checked after a positive ANA when lupus is suspected, and it belongs to the formal classification criteria for the disease. Its defining feature is high specificity for systemic lupus erythematosus (SLE): it very rarely appears in other conditions or in healthy people, so a positive anti-Sm in someone with suggestive features — such as joint pain, characteristic rashes, mouth ulcers, kidney involvement or blood-count changes — strongly supports the diagnosis of lupus. The trade-off is low sensitivity: only a minority of people with lupus (roughly a quarter to a third) actually carry the antibody, so a negative result does not exclude the disease, and other lupus antibodies such as anti-dsDNA may still be positive. Unlike anti-dsDNA, anti-Sm levels are not generally used to track disease activity or flares over time; it functions mainly as a diagnostic and classifying marker. It is often found together with anti-RNP, and is interpreted by a rheumatologist alongside the whole clinical and laboratory picture rather than in isolation.

• Systemic lupus erythematosus (SLE) — highly specific; a positive result strongly supports the diagnosis in someone with suggestive features.
• Part of the classification criteria for lupus — contributes to formally diagnosing the disease.
• Often found with anti-RNP — the two frequently occur together.
• A positive result even with mild symptoms — warrants specialist assessment for lupus.

• Negative — the expected result; but because the antibody is present in only a minority of people with lupus, a negative does NOT rule the disease out.
• Other lupus antibodies may still be positive — anti-dsDNA, ANA and others are interpreted together.